On the recordMarch 21, 2023
It is interesting that you would phrase it that way, because my understanding is that there have been clinical trials, that there is science-based evidence, that this does move the needle.
Source
congress.govEditor's note · Context
Challenges the decision on Alzheimer's drug approval based on existing clinical evidence.
Share & report
More from Shelley Moore Capito
Jul 31, 2024
Madam President, I rise today to address something that is not getting done on time, as it deserves to be done on this Senate floor; and that is the fiscal year 2025 National Defense Authorization Act. I am very pleased to see my fellow…
Jun 12, 2024
Mr. President, here we go again. I rise today in this Chamber as President Biden and his administration enter yet another summer of executive overreach as the administration adds layer after layer of bureaucracy that spells negative…
Apr 16, 2024
I appreciate the somewhat tempered approach this year compared to the previous budgets.
Other voices in this conversation
